These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9523876)

  • 1. Use of octreotide for the treatment of severe gastrointestinal bleeding in children.
    Siafakas C; Fox VL; Nurko S
    J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):356-9. PubMed ID: 9523876
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of octreotide in children with chronic gastrointestinal bleeding.
    Zellos A; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2000 Apr; 30(4):442-6. PubMed ID: 10776959
    [No Abstract]   [Full Text] [Related]  

  • 3. Octreotide therapy for control of acute gastrointestinal bleeding in children.
    Eroglu Y; Emerick KM; Whitingon PF; Alonso EM
    J Pediatr Gastroenterol Nutr; 2004 Jan; 38(1):41-7. PubMed ID: 14676593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.
    O'Meara M; Cicalese MP; Bordugo A; Ambrosi A; Hadzic N; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):48-53. PubMed ID: 25162361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide for palliative treatment of bleeding from unresectable gastric cancer.
    Sanaka M; Yamamoto T; Kawakami T; Kuyama Y
    Hepatogastroenterology; 2005; 52(64):2 p preceding I. PubMed ID: 16001612
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic applications of octreotide in pediatric patients.
    Al-Hussaini A; Butzner D
    Saudi J Gastroenterol; 2012; 18(2):87-94. PubMed ID: 22421712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: octreotide as an adjunct to embolisation in the management of recurrent bleeding upper gastrointestinal metastases from primary renal cell cancer.
    Lamb GW; Moss J; Edwards R; Aitchison M
    Int Urol Nephrol; 2005; 37(4):691-3. PubMed ID: 16362580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report.
    Tamagno G; Mioni R; De Carlo E; Maffei P; Rubello D; Sicolo N
    Dig Liver Dis; 2004 Dec; 36(12):843-6. PubMed ID: 15646433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of octreotide in the immediate control of oesophageal variceal bleeding.
    McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):437-8; author reply 438. PubMed ID: 15448442
    [No Abstract]   [Full Text] [Related]  

  • 11. Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy.
    Molina-Infante J; Perez-Gallardo B; Gonzalez-Garcia G; Fernandez-Bermejo M; Mateos-Rodriguez JM; Robledo-Andres P
    Gut; 2007 Mar; 56(3):447. PubMed ID: 17339258
    [No Abstract]   [Full Text] [Related]  

  • 12. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
    Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
    ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effect of combination of octreotide and omeprazole in children with acute upper gastrointestinal bleeding and the levels of serum creatinine and serum urea nitrogen.
    Hao W; Piao L; Sun M; Zeng F
    Pak J Pharm Sci; 2022 Jan; 35(1(Special)):343-347. PubMed ID: 35236645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?
    Rennyson SL; Shah KB; Tang DG; Kasirajan V; Pedram S; Cahoon W; Malhotra R
    ASAIO J; 2013; 59(4):450-1. PubMed ID: 23820288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Octreotide in bleeding caused by intestinal angiodysplasia].
    Lourdes Ruiz Rebollo M; Barrio Andrés J; Fernández-Orcajo P; Prada Lobato J; Mena Martín FJ; Velicia Llames R; Caro-Paton A
    Gastroenterol Hepatol; 2008 Dec; 31(10):713-4. PubMed ID: 19174089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Octreotide and angiodysplasia].
    Fernández Salazar LI; de la Calle Valverde F; González Hernández JM
    Gastroenterol Hepatol; 2004 Nov; 27(9):558-9. PubMed ID: 15544743
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage.
    Alaniz C; Mohammad RA; Welage LS
    Pharmacotherapy; 2009 Mar; 29(3):248-54. PubMed ID: 19249944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide for control of bleeding peristomal varices in palliative care.
    Selby D; Jackson LD
    J Pain Symptom Manage; 2015 Mar; 49(3):e2-4. PubMed ID: 25543109
    [No Abstract]   [Full Text] [Related]  

  • 19. Terlipressin vs. octreotide in bleeding esophageal varices.
    Krag A; Bendtsen F
    Am J Gastroenterol; 2009 Sep; 104(9):2351; author reply 2351-2. PubMed ID: 19727090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.